CEimpact Podcast

The Shift from Creatinine Clearance to Race-Free eGFR

16 Nov 2026 · 52:04
Courses

Description

Kidney function estimates influence medication dosing, safety, and monitoring decisions across pharmacy practice. This course reviews the shift from Cockcroft-Gault estimated creatinine clearance (CrCl) to the 2021 CKD-EPI race-free estimated glomerular filtration rate (eGFR) equation and what the change means for pharmacy practice. You will be better prepared to use race-free eGFR in medication-related decisions.

HOST
Rachel Maynard, PharmD

GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Andrew Bzowyckyj, PharmD, BCPS, CDCES
Senior Scientific Director, Learning Consultant
National Kidney Foundation

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.
 

Purchase a CE Subscription to get CE credit for this episode.

All episodes, CE, and Practice Resources for the GameChangers Clinical Update are included with a Pharmacist or Technician CE Subscription. But wait…there’s even more!

The Pharmacist & Technician CE Subscriptions include: 
- Compliance and licensure CE 
- GameChangers Clinical Updates
- Practical continuing education across patient care topics 

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. 

CEimpact's CE Subscriptions: All your CE in one convenient subscription. Purchase Now!



PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing a Pharmacist or Technician CE Subscription.

 
CPE REDEMPTION
This course is accredited for continuing pharmacy education! 

If you have a CE Subscription and are ready to claim credit, click the link below for your practice role:

If you do not have a CE Subscription, click here to purchase and claim credit for this episode!


 CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the rationale for transitioning from Cockcroft-Gault estimated creatinine clearance to race-free eGFR for medication-related decision-making.
2. Explain practical considerations for using race-free eGFR in medication-related decisions.

Rachel Maynard and Andrew Bzowyckyj have no relevant financial relationships to disclose.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-376-H01-P/T
Initial release date: 11/16/2026
Expiration date: 11/16/2029
Additional CPE details can be found here for pharmacists and here for pharmacy technicians.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Comments

No comments yet — be the first to write one.